These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 35181460

  • 1. Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.
    Babenko M, Alany RG, Calabrese G, Kaialy W, ElShaer A.
    Int J Pharm; 2022 Apr 05; 617():121601. PubMed ID: 35181460
    [Abstract] [Full Text] [Related]

  • 2. 1H NMR quantification of spray dried and spray freeze-dried saccharide carriers in dry powder inhaler formulations.
    Babenko M, Peron JR, Kaialy W, Calabrese G, Alany RG, ElShaer A.
    Int J Pharm; 2019 Jun 10; 564():318-328. PubMed ID: 30890450
    [Abstract] [Full Text] [Related]

  • 3. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
    Yu H, Teo J, Chew JW, Hadinoto K.
    Int J Pharm; 2016 Feb 29; 499(1-2):38-46. PubMed ID: 26757148
    [Abstract] [Full Text] [Related]

  • 4. Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.
    Kaialy W, Nokhodchi A.
    Pharm Res; 2013 Feb 29; 30(2):458-77. PubMed ID: 23070603
    [Abstract] [Full Text] [Related]

  • 5. Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.
    Son YJ, Worth Longest P, Hindle M.
    Int J Pharm; 2013 Feb 25; 443(1-2):137-45. PubMed ID: 23313343
    [Abstract] [Full Text] [Related]

  • 6. Characterization of excipient enhanced growth (EEG) tobramycin dry powder aerosol formulations.
    Hassan A, Farkas D, Longest W, Hindle M.
    Int J Pharm; 2020 Dec 15; 591():120027. PubMed ID: 33130220
    [Abstract] [Full Text] [Related]

  • 7. Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.
    Kaialy W, Nokhodchi A.
    Eur J Pharm Sci; 2015 Feb 20; 68():56-67. PubMed ID: 25497318
    [Abstract] [Full Text] [Related]

  • 8. Impact of excipient choice on the aerodynamic performance of inhalable spray-freeze-dried powders.
    Wanning S, Süverkrüp R, Lamprecht A.
    Int J Pharm; 2020 Aug 30; 586():119564. PubMed ID: 32590097
    [Abstract] [Full Text] [Related]

  • 9. Focusing on powder processing in dry powder inhalation product development, manufacturing and performance.
    Stegemann S, Faulhammer E, Pinto JT, Paudel A.
    Int J Pharm; 2022 Feb 25; 614():121445. PubMed ID: 34998921
    [Abstract] [Full Text] [Related]

  • 10. Development of a Carrier Free Dry Powder Inhalation Formulation of Ketotifen for Pulmonary Drug Delivery.
    Azari F, Ghanbarzadeh S, Safdari R, Yaqoubi S, Adibkia K, Hamishehkar H.
    Drug Res (Stuttg); 2020 Jan 25; 70(1):26-32. PubMed ID: 31533157
    [Abstract] [Full Text] [Related]

  • 11. Development and Characterization of Excipient Enhanced Growth (EEG) Surfactant Powder Formulations for Treating Neonatal Respiratory Distress Syndrome.
    Boc S, Momin MAM, Farkas DR, Longest W, Hindle M.
    AAPS PharmSciTech; 2021 Apr 15; 22(4):136. PubMed ID: 33860409
    [Abstract] [Full Text] [Related]

  • 12. Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols.
    Muralidharan P, Mallory EK, Malapit M, Phan H, Ledford JG, Hayes D, Mansour HM.
    RSC Adv; 2020 Nov 17; 10(68):41846-41856. PubMed ID: 33391731
    [Abstract] [Full Text] [Related]

  • 13. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
    Li X, Vogt FG, Hayes D, Mansour HM.
    J Aerosol Med Pulm Drug Deliv; 2014 Apr 17; 27(2):81-93. PubMed ID: 24502451
    [Abstract] [Full Text] [Related]

  • 14. Impact of dispersion media and carrier type on spray-dried proliposome powder formulations loaded with beclomethasone dipropionate for their pulmonary drug delivery via a next generation impactor.
    Khan I, Al-Hasani A, Khan MH, Khan AN, -Alam FE, Sadozai SK, Elhissi A, Khan J, Yousaf S.
    PLoS One; 2023 Apr 17; 18(3):e0281860. PubMed ID: 36913325
    [Abstract] [Full Text] [Related]

  • 15. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW, Schneider M, Morrical BD, Imanidis G.
    J Pharm Sci; 2018 Apr 17; 107(4):984-998. PubMed ID: 29247741
    [Abstract] [Full Text] [Related]

  • 16. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
    Shetty N, Park H, Zemlyanov D, Mangal S, Bhujbal S, Zhou QT.
    Int J Pharm; 2018 Jun 10; 544(1):222-234. PubMed ID: 29678544
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of the extra-fine particle fraction of levofloxacin embedded in excipient matrix formulations for dry powder inhaler using response surface methodology.
    Tse JY, Kadota K, Imakubo T, Uchiyama H, Tozuka Y.
    Eur J Pharm Sci; 2021 Jan 01; 156():105600. PubMed ID: 33075466
    [Abstract] [Full Text] [Related]

  • 18. Co-Spray Dried Mannitol/Poly(amidoamine)-Doxorubicin Dry-Powder Inhaler Formulations for Lung Adenocarcinoma: Morphology, In Vitro Evaluation, and Aerodynamic Performance.
    Zhong Q.
    AAPS PharmSciTech; 2018 Feb 01; 19(2):531-540. PubMed ID: 28840529
    [Abstract] [Full Text] [Related]

  • 19. Large porous particles for respiratory drug delivery. Glycine-based formulations.
    Ogienko AG, Bogdanova EG, Trofimov NA, Myz SA, Ogienko AA, Kolesov BA, Yunoshev AS, Zubikov NV, Manakov AY, Boldyrev VV, Boldyreva EV.
    Eur J Pharm Sci; 2017 Dec 15; 110():148-156. PubMed ID: 28479348
    [Abstract] [Full Text] [Related]

  • 20. Understanding the impact of mannitol on physical stability and aerosolization of spray-dried protein powders for inhalation.
    Arte KS, Tower CW, Mutukuri TT, Chen Y, Patel SM, Munson EJ, Tony Zhou Q.
    Int J Pharm; 2024 Jan 25; 650():123698. PubMed ID: 38081559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.